Feedbacks, Bifurcations, and Cell Fate Decision-Making in the p53 System
暂无分享,去创建一个
Tomasz Lipniacki | Beata Hat | Marek Kochanczyk | Marta N. Bogdal | M. Kochańczyk | T. Lipniacki | B. Hat
[1] B. Vogelstein,et al. Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.
[2] Jing Li,et al. Wip1-deficient mice are resistant to common cancer genes. , 2004, Trends in molecular medicine.
[3] T. Hofmann,et al. Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR , 2008, Nature Cell Biology.
[4] Keng Boon Wee,et al. Akt versus p53 in a network of oncogenes and tumor suppressor genes regulating cell survival and death. , 2006, Biophysical journal.
[5] R. Parsons,et al. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene. , 1998, Cancer research.
[6] T. Mak,et al. Regulation of PTEN transcription by p53. , 2001, Molecular cell.
[7] J. Ptak,et al. High Frequency of Mutations of the PIK3CA Gene in Human Cancers , 2004, Science.
[8] P. Donahoe,et al. Requirement for phosphatidylinositol-3'-kinase in cytokine-mediated germ cell survival during fetal oogenesis in the mouse. , 1999, Endocrinology.
[9] David J. Arenillas,et al. Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer , 2008, Journal of Cell Science.
[10] Eshel Ben-Jacob,et al. MicroRNA-based regulation of epithelial–hybrid–mesenchymal fate determination , 2013, Proceedings of the National Academy of Sciences.
[11] C. Prives,et al. Blinded by the Light: The Growing Complexity of p53 , 2009, Cell.
[12] D. Gillespie. Exact Stochastic Simulation of Coupled Chemical Reactions , 1977 .
[13] M. Oren,et al. mdm2 expression is induced by wild type p53 activity. , 1993, The EMBO journal.
[14] Cristina M. Pinto,et al. Retracted: Frequent genetic and biochemical alterations of the PI 3‐K/AKT/PTEN pathway in head and neck squamous cell carcinoma , 2005, International journal of cancer.
[15] Akira Nakagawara,et al. PPM1D is a potential target for 17q gain in neuroblastoma. , 2003, Cancer research.
[16] M. Rocchi,et al. Molecular cloning, cDNA sequence, and chromosomal localization of the human phosphatidylinositol 3-kinase p110 alpha (PIK3CA) gene. , 1994, Genomics.
[17] Paul Brazhnik,et al. Exploring Mechanisms of the DNA-Damage Response: p53 Pulses and their Possible Relevance to Apoptosis , 2007, Cell cycle.
[18] G. Lahav,et al. Recurrent initiation: a mechanism for triggering p53 pulses in response to DNA damage. , 2008, Molecular cell.
[19] E. Stavridi,et al. Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[20] Qian Yang,et al. Nuclear Factor-κB (NF-κB) Is a Novel Positive Transcriptional Regulator of the Oncogenic Wip1 Phosphatase* , 2009, The Journal of Biological Chemistry.
[21] Tomasz Lipniacki,et al. Levels of pro-apoptotic regulator Bad and anti-apoptotic regulator Bcl-xL determine the type of the apoptotic logic gate , 2013, BMC Systems Biology.
[22] D R Alessi,et al. PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? , 2001, Journal of cell science.
[23] T. Hofmann,et al. Homeodomain-interacting protein kinase 2 is the ionizing radiation-activated p53 serine 46 kinase and is regulated by ATM. , 2007, Cancer research.
[24] U Alon,et al. Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[25] D. Ginsberg,et al. E2F1 Modulates p38 MAPK Phosphorylation via Transcriptional Regulation of ASK1 and Wip1* , 2006, Journal of Biological Chemistry.
[26] J. Levine,et al. Surfing the p53 network , 2000, Nature.
[27] Y Taya,et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. , 1998, Science.
[28] George Lliakis,et al. The role of DNA double strand breaks in lonizing radiation‐induced killing of eukaryotic cells , 1991 .
[29] Lewis C Cantley,et al. The phosphoinositide 3-kinase pathway. , 2002, Science.
[30] Uri Alon,et al. Dynamics of the p53-Mdm2 feedback loop in individual cells , 2004, Nature Genetics.
[31] James R Faeder,et al. Rule-based modeling of biochemical systems with BioNetGen. , 2009, Methods in molecular biology.
[32] J C Reed,et al. Dysregulation of apoptosis in cancer. , 1998, The cancer journal from Scientific American.
[33] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[34] Xiongbin Lu,et al. The Wip1 phosphatase and Mdm2: Cracking the "Wip" on p53 stability , 2008, Cell cycle.
[35] Frank McCormick,et al. High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma. , 2005, Cancer research.
[36] John Jeremy Rice,et al. A plausible model for the digital response of p53 to DNA damage. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[37] Xin Huang,et al. Somatic mutation and gain of copy number of PIK3CA in human breast cancer , 2005, Breast Cancer Research.
[38] Kyucheol Cho,et al. Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIK3CA amplification in gastric carcinoma , 2003, International journal of cancer.
[39] Daniel Isnardon,et al. TP53INP1s and Homeodomain-interacting Protein Kinase-2 (HIPK2) Are Partners in Regulating p53 Activity* , 2003, Journal of Biological Chemistry.
[40] Giulia Piaggio,et al. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis , 2002, Nature Cell Biology.
[41] James E. Ferrell,et al. A positive-feedback-based bistable ‘memory module’ that governs a cell fate decision , 2007, Nature.
[42] Bo Stenerlöw,et al. Measurement of Prompt DNA Double-Strand Breaks in Mammalian Cells without Including Heat-Labile Sites: Results for Cells Deficient in Nonhomologous End Joining , 2002, Radiation research.
[43] Se Jin Jang,et al. The Estrogen Receptor α Pathway Induces Oncogenic Wip1 Phosphatase Gene Expression , 2009, Molecular Cancer Research.
[44] A. Levine,et al. The p53 pathway: positive and negative feedback loops , 2005, Oncogene.
[45] G. Wahl,et al. MDM2, MDMX and p53 in oncogenesis and cancer therapy , 2013, Nature Reviews Cancer.
[46] M. Fiscella,et al. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[47] Joel Keizer,et al. Statistical Thermodynamics of Nonequilibrium Processes , 1987 .
[48] Wei Gu,et al. p53 ubiquitination: Mdm2 and beyond. , 2006, Molecular cell.
[49] Albert J. Fornace,et al. Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase , 2006, The Journal of experimental medicine.
[50] Wei Wang,et al. Two-phase dynamics of p53 in the DNA damage response , 2011, Proceedings of the National Academy of Sciences.
[51] M. Wigler,et al. PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.
[52] Zdenek Kolar,et al. Tumour suppressor PTEN regulates cell cycle and protein kinase B/Akt pathway in breast cancer cells. , 2006, Anticancer research.
[53] Masahiro Nakagawa,et al. Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins. , 2011, Blood.
[54] Päivikki Kauraniemi,et al. The serine-threonine protein phosphatase PPM1D is frequently activated through amplification in aggressive primary breast tumours , 2006, Breast Cancer Research and Treatment.
[55] Y Taya,et al. DNA damage induces phosphorylation of the amino terminus of p53. , 1997, Genes & development.
[56] Zigang Dong,et al. Post-translational modification of p53 in tumorigenesis , 2004, Nature Reviews Cancer.
[57] F. E. Bertrand,et al. CBF-1 (RBP-Jk) Binds to the PTEN Promoter and Regulates PTEN Gene Expression , 2007, Cell cycle.
[58] Yoichi Taya,et al. DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2 , 1997, Cell.
[59] Wei Wang,et al. Coordination between Cell Cycle Progression and Cell Fate Decision by the p53 and E2F1 Pathways in Response to DNA Damage* , 2010, The Journal of Biological Chemistry.
[60] Y Taya,et al. DNA damage‐inducible phosphorylation of p53 at N‐terminal sites including a novel site, Ser20, requires tetramerization , 1999, The EMBO journal.
[61] Tomasz Lipniacki,et al. Oscillations and bistability in the stochastic model of p53 regulation. , 2008, Journal of theoretical biology.
[62] Takashi Kumagai,et al. PTEN promoter is methylated in a proportion of invasive breast cancers , 2004, International journal of cancer.
[63] Yoichi Taya,et al. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2 , 2002, Nature Cell Biology.
[64] Ettore Appella,et al. ATM Mediates Phosphorylation at Multiple p53 Sites, Including Ser46, in Response to Ionizing Radiation* , 2002, The Journal of Biological Chemistry.
[65] P. Peltomäki,et al. Patterns of PIK3CA alterations in familial colorectal and endometrial carcinoma , 2007, International journal of cancer.
[66] J Downward,et al. PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. , 1997, Trends in biochemical sciences.
[67] Kai Rothkamm,et al. Pathways of DNA Double-Strand Break Repair during the Mammalian Cell Cycle , 2003, Molecular and Cellular Biology.
[68] S. Knuutila,et al. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. , 1998, The American journal of pathology.
[69] 平沢 晃,et al. Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of PPM1D and APPBP2 as likely amplification targets , 2004 .
[70] Pier Paolo Pandolfi,et al. The PTEN–PI3K pathway: of feedbacks and cross-talks , 2008, Oncogene.
[71] Y Taya,et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. , 1998, Science.
[72] Xiongbin Lu,et al. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop. , 2007, Cancer cell.
[73] G. Iliakis,et al. The role of DNA double strand breaks in ionizing radiation-induced killing of eukaryotic cells. , 1991, BioEssays : news and reviews in molecular, cellular and developmental biology.
[74] S. Leibler,et al. Biological rhythms: Circadian clocks limited by noise , 2000, Nature.
[75] M. Oren,et al. Mdm2 promotes the rapid degradation of p53 , 1997, Nature.
[76] Anthony J. Davis,et al. Autophosphorylation at serine 1981 stabilizes ATM at DNA damage sites , 2009, The Journal of cell biology.
[77] Kunihiko Kaneko,et al. Molecular discreteness in reaction-diffusion systems yields steady states not seen in the continuum limit. , 2003, Physical review. E, Statistical, nonlinear, and soft matter physics.
[78] Ryan A. Kellogg,et al. Spontaneous NF-κB Activation by Autocrine TNFα Signaling: A Computational Analysis , 2013, PloS one.
[79] Gideon Rechavi,et al. HIPK2 modulates p53 activity towards pro-apoptotic transcription , 2009, Molecular Cancer.
[80] John Calvin Reed,et al. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.
[81] Nathalie Perreault,et al. The PTEN Phosphatase Controls Intestinal Epithelial Cell Polarity and Barrier Function: Role in Colorectal Cancer Progression , 2010, PloS one.
[82] Alberto Gandolfi,et al. The Pharmacodynamics of the p53-Mdm2 Targeting Drug Nutlin: The Role of Gene-Switching Noise , 2014, PLoS Comput. Biol..
[83] A. Levine,et al. Surfing the p53 network , 2000, Nature.
[84] Toshiyuki Obata,et al. Akt Enhances Mdm2-mediated Ubiquitination and Degradation of p53* , 2002, The Journal of Biological Chemistry.
[85] S. Elmore. Apoptosis: A Review of Programmed Cell Death , 2007, Toxicologic pathology.
[86] Stephen N. Jones,et al. Regulation of p53 stability by Mdm2 , 1997, Nature.
[87] Ettore Appella,et al. Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites , 2008, Nucleic acids research.
[88] J. Ferrell,et al. A positive-feedback-based bistable ‘memory module’ that governs a cell fate decision , 2003, Nature.
[89] Albert J. Fornace,et al. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity , 2002, Nature Genetics.
[90] W. K. Alfred Yung,et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , 1997, Nature Genetics.
[91] Andrius Kazlauskas,et al. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase , 1995, Cell.
[92] Lawrence A. Donehower,et al. Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D , 2007, Journal of Neuro-Oncology.
[93] Kim Sneppen,et al. Multistability with a metastable mixed state. , 2012, Physical review letters.
[94] L. Mayo,et al. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[95] Edda Klipp,et al. Systems Biology , 1994 .
[96] A. Levine. p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.
[97] Albert J. Fornace,et al. Chemical inhibition of Wip1 phosphatase contributes to suppression of tumorigenesis , 2005, Cancer biology & therapy.
[98] Eshel Ben-Jacob,et al. Turning Oscillations Into Opportunities: Lessons from a Bacterial Decision Gate , 2013, Scientific Reports.
[99] Z. Cheng,et al. Cell fate decision mediated by p53 pulses , 2009, Proceedings of the National Academy of Sciences.
[100] G. Selivanova,et al. Pharmacological reactivation of p53 as a strategy to treat cancer , 2015, Journal of internal medicine.
[101] Uttam Surana,et al. Oscillations of the p53-Akt Network: Implications on Cell Survival and Death , 2009, PloS one.
[102] E. Kandel,et al. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. , 1999, Experimental cell research.
[103] T. Lipniacki,et al. Exploring mechanisms of oscillations in p53 and nuclear factor-B systems. , 2009, IET systems biology.
[104] F. Schlögl,et al. J. Keizer: “Statistical Thermodynamics of Nonequilibrium Processes”, Springer‐Verlag, New York, Berlin, Heidelberg, London, Paris, Tokyo 1987. 506 Seiten, Preis: DM 128,–. , 1989 .
[105] C Béroud,et al. p53 Website and analysis of p53 gene mutations in human cancer: Forging a link between epidemiology and carcinogenesis , 2000, Human mutation.
[106] A. Arkin,et al. Stochastic amplification and signaling in enzymatic futile cycles through noise-induced bistability with oscillations. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[107] R. Milo,et al. Oscillations and variability in the p53 system , 2006, Molecular systems biology.
[108] G. Panayotou,et al. Phosphoinositide 3-kinases: a conserved family of signal transducers. , 1997, Trends in biochemical sciences.
[109] Xin Ma,et al. NOTCH1 functions as an oncogene by regulating the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma. , 2013, Urologic oncology.
[110] Masaaki Adachi,et al. p53‐inducible Wip1 phosphatase mediates a negative feedback regulation of p38 MAPK‐p53 signaling in response to UV radiation , 2000, The EMBO journal.
[111] S. T. Kim,et al. ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. , 2001, Genes & development.
[112] Wayne A. Phillips,et al. Mutation of the PIK3CA Gene in Ovarian and Breast Cancer , 2004, Cancer Research.
[113] C Eng,et al. PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways. , 2001, Human molecular genetics.
[114] William S. Hlavacek,et al. Computational Analysis of an Autophagy/Translation Switch Based on Mutual Inhibition of MTORC1 and ULK1 , 2015, PloS one.
[115] M. Ehrenberg,et al. Stochastic focusing: fluctuation-enhanced sensitivity of intracellular regulation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[116] U. Knippschild,et al. Posttranslational modification of MDM2. , 2003, Molecular cancer research : MCR.
[117] E. Yu,et al. Expression of a Homeostatic Regulator, Wip1 (Wild-type p53-induced Phosphatase), Is Temporally Induced by c-Jun and p53 in Response to UV Irradiation* , 2010, The Journal of Biological Chemistry.
[118] Lawrence A. Donehower,et al. Mice Deficient for the Wild-Type p53-Induced Phosphatase Gene (Wip1) Exhibit Defects in Reproductive Organs, Immune Function, and Cell Cycle Control , 2002, Molecular and Cellular Biology.
[119] Andrea Ciliberto,et al. Steady States and Oscillations in the p53/Mdm2 Network , 2005, Cell cycle.
[120] Li Mao,et al. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[121] Mariano Provencio,et al. Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype , 1999, Breast Cancer Research and Treatment.
[122] R. Mirzayans,et al. New Insights into p53 Signaling and Cancer Cell Response to DNA Damage: Implications for Cancer Therapy , 2012, Journal of biomedicine & biotechnology.
[123] Jeffrey R. Marks,et al. Oncogenic properties of PPM1D located within a breast cancer amplification epicenter at 17q23 , 2002, Nature Genetics.
[124] Z. Weng,et al. A Global Map of p53 Transcription-Factor Binding Sites in the Human Genome , 2006, Cell.
[125] A. Knudson,et al. Endogenous DNA double-strand breaks: Production, fidelity of repair, and induction of cancer , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[126] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[127] M. Kastan,et al. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation , 2003, Nature.
[128] E. Appella,et al. Wip1 phosphatase modulates ATM-dependent signaling pathways. , 2006, Molecular cell.